n.a. (CXM)

0.65
0.01 1.52
OTC
Prev Close 0.66
Open 0.67
Day Low/High 0.61 / 0.67
52 Wk Low/High 0.50 / 3.48
Volume 52.56K
Exchange OTC
Div & Yield N.A. (N.A)

Latest News

New Technological Survey Exposes Massive Copper Deposit

New Technological Survey Exposes Massive Copper Deposit

Carmax Mining Develops Copper Resource in British Columbia

3 Biotech Stocks Under $10 to Watch

3 Biotech Stocks Under $10 to Watch

Keep an eye on these biotech stocks under $10.

Biotech 2013 by the Numbers: A Blockbuster Year

Biotech 2013 by the Numbers: A Blockbuster Year

The biotech sector closed 2013 up 65%, greatly outperforming the broader markets.

Cardium Reports On Advancement Of Generx And Excellagen Biologic Products And Corporate Developments

Cardium Reports On Advancement Of Generx And Excellagen Biologic Products And Corporate Developments

Clinical and Preclinical Results Have Implications for Use of Generx as a Non-Surgical Gene Therapy for Coronary Artery Disease, and Excellagen to Potentiate Stem Cell Therapies

LifeAgain's Bluemetric Select Life Insurance Now Offered At Lifequotes.com

LifeAgain's Bluemetric Select Life Insurance Now Offered At Lifequotes.com

First National Direct Life Insurance Marketing Company to Offer LifeAgain's BlueMetric Select Life Insurance Program for Men with Active Localized Prostate Cancer

3 Biotech Stocks Under $10 Making Big Moves

3 Biotech Stocks Under $10 Making Big Moves

Keep these under-$10 biotech stocks on your radar.

LifeAgain Announces Recognition Of National Prostate Cancer Awareness Month

LifeAgain Announces Recognition Of National Prostate Cancer Awareness Month

LifeAgain Launches BlueMetric Select Term Life Insurance - First Program Designed for Men with Active Localized Prostate Cancer

LifeAgain Supports Life Insurance Awareness Month

LifeAgain Supports Life Insurance Awareness Month

LifeAgain Launches BlueMetric Select Term Life Insurance - First Program Designed for Men with Active Localized Prostate Cancer

Cardium's LifeAgain Announces Commercialization Agreement With AgencyONE Based On Advanced Medical Data Analytics Platform Technology

Cardium's LifeAgain Announces Commercialization Agreement With AgencyONE Based On Advanced Medical Data Analytics Platform Technology

Pioneering New and Innovative Life Insurance for Men with Active Localized Prostate Cancer

Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties

Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties

The Company Also Provides Update on CE Mark Submission

Cardium Announces Reverse Stock Split

Cardium Announces Reverse Stock Split

Cardium Announces Final Voting Results Of Annual Meeting Of Stockholders

Cardium Announces Final Voting Results Of Annual Meeting Of Stockholders

Company Also Provides Update on Exchange Listing